537 related articles for article (PubMed ID: 15104557)
1. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.
Johannsson G; Sunnerhagen KS; Svensson J
Clin Endocrinol (Oxf); 2004 May; 60(5):550-9. PubMed ID: 15104557
[TBL] [Abstract][Full Text] [Related]
2. The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients.
Götherström G; Bengtsson BA; Sunnerhagen KS; Johannsson G; Svensson J
Clin Endocrinol (Oxf); 2005 Jan; 62(1):105-13. PubMed ID: 15638878
[TBL] [Abstract][Full Text] [Related]
3. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
[TBL] [Abstract][Full Text] [Related]
4. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
Wilhelm B; Kann PH
Med Klin (Munich); 2004 Oct; 99(10):569-77. PubMed ID: 15490072
[TBL] [Abstract][Full Text] [Related]
5. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
Feldt-Rasmussen U; Wilton P; Jonsson P; ;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
[TBL] [Abstract][Full Text] [Related]
6. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
7. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
[TBL] [Abstract][Full Text] [Related]
8. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
[TBL] [Abstract][Full Text] [Related]
9. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
11. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
12. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
[TBL] [Abstract][Full Text] [Related]
13. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.
Götherström G; Bengtsson BA; Bosaeus I; Johannsson G; Svensson J
Eur J Endocrinol; 2007 Jan; 156(1):55-64. PubMed ID: 17218726
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density and body composition in adolescents with childhood-onset growth hormone deficiency.
Boot AM; van der Sluis IM; Krenning EP; de Muinck Keizer-Schrama SM
Horm Res; 2009; 71(6):364-71. PubMed ID: 19506395
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities in bone mineral density distribution and bone scintigraphy in patients with childhood onset hypopituitarism.
Kosowicz J; El Ali Z; Ziemnicka K; Sowinski J
J Clin Densitom; 2007; 10(3):332-9. PubMed ID: 17470407
[TBL] [Abstract][Full Text] [Related]
16. Baseline characteristics and the effects of two years of growth hormone (GH) replacement therapy in adults with GH deficiency previously treated for acromegaly.
Norrman LL; Johannsson G; Sunnerhagen KS; Svensson J
J Clin Endocrinol Metab; 2008 Jul; 93(7):2531-8. PubMed ID: 18397981
[TBL] [Abstract][Full Text] [Related]
17. Baseline characteristics and effects of ten years of growth hormone (GH) replacement therapy in adults previously treated with pituitary irradiation.
Elbornsson M; Götherström G; Bengtsson BÅ; Johannsson G; Svensson J
Growth Horm IGF Res; 2013 Dec; 23(6):249-55. PubMed ID: 24103227
[TBL] [Abstract][Full Text] [Related]
18. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
[TBL] [Abstract][Full Text] [Related]
19. Comparison of glucose and lipid metabolism and bone mineralization in patients with growth hormone deficiency with and without long-term growth hormone replacement.
Roemmler J; Kuenkler M; Schneider HJ; Dieterle C; Schopohl J
Metabolism; 2010 Mar; 59(3):350-8. PubMed ID: 19800640
[TBL] [Abstract][Full Text] [Related]
20. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
